{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:12:14Z","timestamp":1778231534094,"version":"3.51.4"},"reference-count":55,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015579","name":"3m foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["INQUIRY"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>Chlorhexidine gluconate (CHG)-containing dressings are recommended to prevent central line associated bloodstream infections (CLABSIs) and other catheter-related infections. This study compared the effect of 2 CHG dressings on CLABSI, cost of care, and contact dermatitis. A retrospective analysis was conducted using the Premier Healthcare Database of hospitalized patients (n\u2009=\u200953\u2009149) with central venous catheters (CVCs) and receiving either a transparent CHG gel dressing (n\u2009=\u200914\u2009488) or an opaque CHG sponge dressing (n\u2009=\u200938\u2009661) between January 2019 and September 2020. Two cohorts (n\u2009=\u200914\u2009488 each), CHG-Gel and CHG-Sponge, were matched 1:1 using a propensity score method on 33 patient and facility characteristics. CLABSI and contact dermatitis rates, hospital length of stay (LOS), and hospitalization costs were compared using mixed-effect multiple regression. This approach effectively controlled for random clustering effects across hospitals and patients\u2019 Diagnosis-Related Group (DRG) classifications. CHG gel dressings were associated with a 41% decrease in CLABSI rates ( P\u2009=\u2009.0008) compared to CHG sponge dressings (0.35%vs 0.60%). A 0.4-day shorter LOS (9.53vs 9.90\u2009days, P\u2009=\u2009.0001) and a cost saving of $3576 per hospital stay ($40\u2009197 vs $43\u2009774, P\u2009=\u2009.0179) was observed with CHG gel dressing use. There was no statistically significant difference in contact dermatitis rates ( P\u2009=\u2009.7854) between the CHG-Gel and CHG-Sponge cohorts. The findings of this study suggest that the use of CHG gel dressings may be more effective in reducing the risk of CLABSIs and associated clinical costs compared to CHG sponge dressings in hospitalized patients. Moreover, there appears to be no significant discrepancy in contact dermatitis rates between CHG gel and CHG sponge dressings. Healthcare providers may consider using CHG gel dressings as a standard practice for patients with CVCs to reduce the risk of infections and improve patient outcomes.<\/jats:p>","DOI":"10.1177\/00469580231214751","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T05:25:26Z","timestamp":1701408326000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative Effectiveness of 2 Chlorhexidine Gluconate-Containing Dressings in Reducing Central Line-Associated Bloodstream Infections, Hospital Stay, and Costs"],"prefix":"10.1177","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4986-8922","authenticated-orcid":false,"given":"Yuefeng","family":"Hou","sequence":"first","affiliation":[{"name":"3M Health Care, 3M Company, Austin, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Griffin","sequence":"additional","affiliation":[{"name":"3M Health Care, 3M Company, San Antonio, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2908-4581","authenticated-orcid":false,"given":"St\u00e9phanie F.","family":"Bernatchez","sequence":"additional","affiliation":[{"name":"3M Health Care, 3M Company, St. Paul, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Hommes","sequence":"additional","affiliation":[{"name":"3M Health Care, 3M Company, St. Paul, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarja","family":"K\u00e4rp\u00e4nen","sequence":"additional","affiliation":[{"name":"3M Health Care, 3M Deutschland GmbH, Neuss, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Palka-Santini","sequence":"additional","affiliation":[{"name":"3M Health Care, 3M Deutschland GmbH, Neuss, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"bibr1-00469580231214751","unstructured":"CDC. National and state healthcare-associated infections progress report. 2021. Accessed May 30, 2023. https:\/\/www.cdc.gov\/hai\/data\/portal\/progress-report.html."},{"key":"bibr2-00469580231214751","unstructured":"Chopra V, Felix K, Johns K, et al. Central Line-Associated Bloodstream Infection (CLABSI): An Introduction. Centers of Disease Control and Prevention. 2020. Accessed May 26, 2023. https:\/\/www.cdc.gov\/infectioncontrol\/pdf\/strive\/CLABSI101-508.pdf"},{"key":"bibr3-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-014-0689-y"},{"key":"bibr4-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12407"},{"key":"bibr5-00469580231214751","doi-asserted-by":"publisher","DOI":"10.5301\/jva.5000658"},{"key":"bibr6-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201206-1038OC"},{"key":"bibr7-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-013-0519-7"},{"key":"bibr8-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw275"},{"key":"bibr9-00469580231214751","doi-asserted-by":"publisher","DOI":"10.5301\/jva.5000596"},{"key":"bibr10-00469580231214751","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.342.14810"},{"key":"bibr11-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4029-9"},{"key":"bibr12-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.376"},{"key":"bibr13-00469580231214751","doi-asserted-by":"publisher","DOI":"10.2309\/java.13-3-3"},{"key":"bibr14-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2013.03.283"},{"key":"bibr15-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2011.03.030"},{"key":"bibr16-00469580231214751","author":"Maki D","year":"2008","journal-title":"Soc Heal Care Epidemiol Am"},{"key":"bibr17-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-015-0202-5"},{"key":"bibr18-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03174-0"},{"key":"bibr19-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2011.01.003"},{"key":"bibr20-00469580231214751","unstructured":"NICE. Tegaderm CHG securement dressing for vascular access sites in critically ill adults (MTG25). 2015. Last updated 2019. Accessed April 25, 2023. https:\/\/www.nice.org.uk\/guidance\/mtg25"},{"key":"bibr21-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2022.87"},{"key":"bibr22-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-016-0116-5"},{"key":"bibr23-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1097\/NAN.0000000000000396"},{"key":"bibr24-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1086\/676533"},{"issue":"2017","key":"bibr25-00469580231214751","first-page":"1","volume":"2017","author":"Talbot T","year":"2017","journal-title":"Cent Dis Control Prev Natl Cent Emerg Borne Infect Dis Div Heal Qual Promot"},{"key":"bibr26-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05617-x"},{"key":"bibr27-00469580231214751","unstructured":"PINC AI\u2122 Healthcare Data White Paper: Data that informs and performs, September 14, 2021. PINC AI\u2122 Applied Sciences, Premier Inc. Accessed April 26, 2023. https:\/\/offers.premierinc.com\/rs\/381-NBB-525\/images\/Premier-Healthcare-Database-Whitepaper-Final.pdf"},{"key":"bibr28-00469580231214751","unstructured":"US Dept of Health and Human Services. Code of Federal Regulations, title 45 CFR 46. 2018. Accessed April 26, 2023. https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/regulations\/45-cfr-46\/common-rule-subpart-a-46104\/index.html"},{"key":"bibr29-00469580231214751","unstructured":"National Cancer Institute. SEER-Medicare: Comorbidity SAS Macros. Accessed September 8, 2023. https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/considerations\/calculation.html"},{"key":"bibr30-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003857"},{"key":"bibr31-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2014.81"},{"key":"bibr32-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2016.1141162"},{"key":"bibr33-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2011.01.018"},{"key":"bibr34-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2016.1141161"},{"key":"bibr35-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1177\/1757177417720998"},{"key":"bibr36-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1547385"},{"key":"bibr37-00469580231214751","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14947"},{"issue":"1","key":"bibr38-00469580231214751","volume":"5","author":"Mehta B","year":"2019","journal-title":"RMD"},{"key":"bibr39-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.05.011"},{"key":"bibr40-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-022-04501-9"},{"key":"bibr41-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"bibr42-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"bibr43-00469580231214751","volume":"14","author":"Toor H","year":"2022","journal-title":"Cureus"},{"key":"bibr44-00469580231214751","doi-asserted-by":"publisher","DOI":"10.2307\/30141155"},{"key":"bibr45-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq108"},{"key":"bibr46-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200212000-00003"},{"key":"bibr47-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1201-0"},{"key":"bibr48-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1097\/HCM.0b013e31818c8037"},{"key":"bibr49-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1177\/1062860608331241"},{"key":"bibr50-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000319"},{"key":"bibr51-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2021.70"},{"key":"bibr52-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2021.108"},{"key":"bibr53-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2021.280"},{"key":"bibr54-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2022.116"},{"key":"bibr55-00469580231214751","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31824e0d46"}],"container-title":["INQUIRY: The Journal of Health Care Organization, Provision, and Financing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00469580231214751","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00469580231214751","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00469580231214751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:08:41Z","timestamp":1777460921000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00469580231214751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":55,"alternative-id":["10.1177\/00469580231214751"],"URL":"https:\/\/doi.org\/10.1177\/00469580231214751","relation":{},"ISSN":["0046-9580","1945-7243"],"issn-type":[{"value":"0046-9580","type":"print"},{"value":"1945-7243","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"article-number":"00469580231214751"}}